Drug Type Small molecule drug |
Synonyms Binaprofen, Felbinac, 万舒安 |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC18H23NO5 |
InChIKeySWKYVGAYFCGGRP-UHFFFAOYSA-N |
CAS Registry935886-64-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pain, Postoperative | NDA/BLA | China | 10 Jul 2024 | |
| Pain, Postoperative | NDA/BLA | China | 10 Jul 2024 | |
| Pain | NDA/BLA | - | - | |
| Low Back Pain | Phase 3 | China | 10 May 2021 | |
| Low Back Pain | Phase 3 | China | 10 May 2021 | |
| Nephrolithiasis | Phase 3 | China | 10 May 2021 | |
| Nephrolithiasis | Phase 3 | China | 10 May 2021 | |
| Neuralgia | Phase 3 | China | 10 May 2021 | |
| Neuralgia | Phase 3 | China | 10 May 2021 | |
| Cancer Pain | Phase 3 | China | 08 Apr 2021 |





